183 results
Page 2 of 10
20-F/A
EX-12.2
8h7 b2os9
9 Sep 22
Annual report (foreign) (amended)
4:15pm
6-K
EX-99
ar82d 29p
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
sc9zbn 1t1hfxc
16 Jun 22
BioLineRx Announces Appointment of Commercial Strategy
7:05am
6-K
EX-99
nb26r tf4
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-99
tlkl tq7bsb
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
6-K
EX-10.1
p2nn wuk0aa
3 Sep 21
Current report (foreign)
4:30pm
424B5
bfwiwufmpk9i1bbqj3
3 Sep 21
Prospectus supplement for primary offering
4:29pm
POS AM
p3lc414m8ptbv ls
23 Feb 21
Prospectus update (post-effective amendment)
9:12am
6-K
EX-99
42juscdliu7sq da8w2
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
hvb22 x6d127ae50isi
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
g83wlj d8h
19 Jan 21
Prospectus supplement for primary offering
5:00pm